Walleye Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,700
Closed -$329K 5471
2024
Q3
$329K Sell
17,700
-27,900
-61% -$470K ﹤0.01% 3663
2024
Q2
$702K Buy
45,600
+40,000
+714% +$572K ﹤0.01% 3181
2024
Q1
$82.7K Buy
+5,600
New +$77.5K ﹤0.01% 4488
2020
Q1
Sell
-19,800
Closed -$423K 1542
2019
Q4
$423K Buy
19,800
+100
+0.5% +$2.24K 0.03% 760
2019
Q3
$452K Buy
+19,700
New +$420K 0.03% 812

Other funds holding SBRA

Walleye Capital's SBRA Position: Q2 2025 in Review

Walleye Capital sold out of Sabra Healthcare REIT (SBRA) in Q2 2025, closing a stake of 96,627 shares — an estimated $1.69M sold.

Walleye Capital first reported a position in SBRA in Q4 2019 and held it in 14 quarters. The position peaked at $2.63M in Q2 2022. 396 funds tracked by Wall St. Rank hold SBRA as of Q2 2025.

  • Walleye Capital reported no remaining Sabra Healthcare REIT position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 96,627 Sabra Healthcare REIT shares in Q2 2025, an estimated $1.69M.
  • Walleye Capital first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 14 quarters.
  • Walleye Capital's Sabra Healthcare REIT position peaked at $2.63M in Q2 2022.
  • 396 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.